Most treatments to date are centered around treating the symptoms caused by the disease or for discouraging the initiation of fibrosis (Fallo & Sarnacchiaro, 2019) (Gonzalez-Cadavid & Rajfer, 2010)
Bilirubin benefits: Cellular protection by a biliverdin reductase antioxidant cycle
Researched effects In a diet-induced-obese mouse study (Neelakantan et al., Biochemical Pharmacology, 2018), subcutaneous 5-Amino-1MQ (20 mg/kg, three times daily, roughly 11 days) produced about 5.1% body-weight loss versus continued weight gain in untreated controls, roughly 35% less epididymal white fat mass, smaller adipocytes, lower plasma cholesterol, and improved glucose tolerance, with no reported change in food intake and no observed adverse effects in the mice
For gastrointestinal applications, protocols of 14 to 28 days have been studied